Business Model

At Secarna, we are flexible and can accommodate any meaningfully structured alliance across all stages of discovery and pre-clinical development.

Our flexible partnership model is set to accommodate the best mix of in-house and partner collaborations. Three typical structures are found in our partnership portfolio:

Program Licenses: Single asset deals to out-license high-value, non-core assets for further development and commercialization by partners

In-house development: High value programs progressed to pre-clinical proof-of-concept and first-in-human/early stage clinical studies followed by the potential out-licensing of these candidates to partners

Discovery & Research Alliances: Platform deals for broader discovery and development collaborations leveraging Secarna’s entire toolbox to generate partnered and co-owned ASO pipelines

Our objective is to become the partner-of-choice for antisense drug discovery and development programs and to form strategic partnerships fully leveraging our collaborators’ as well as our strengths.

Current Partnerships

Currently, we have a total of ten disclosed commercial partnerships.

If you are interested in collaborating with Secarna, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it..